Literature DB >> 10903013

Marked enhancement of anti-allodynic effect by combined intrathecal administration of the adenosine A1-receptor agonist R-phenylisopropyladenosine and morphine in a rat model of central pain.

M von Heijne1, J X Hao, A Sollevi, X J Xu, Z Wiesenfeld-Hallin.   

Abstract

BACKGROUND: There is often no satisfactory treatment for chronic pain after spinal cord injury. We have previously reported that intrathecal (i.t.) administration of the adenosine A1-receptor agonist R-phenylisopropyl-adenosine (R-PIA) or the opioid morphine has anti-allodynic effects in a model of presumed chronic central pain after photochemically induced spinal cord injury in rats. In the present study, we set out to investigate the possible interaction between i.t. R-PIA and morphine in spinally injured rats.
METHODS: Sprague-Dawley rats displaying allodynia-like behaviors to mechanical and cold stimuli after photochemically induced spinal cord injury with minor motor deficits were used. R-PIA and morphine, either alone or in combination, were administered i.t. through an implanted catheter to lumbar spinal cord.
RESULTS: Cumulative doses of R-PIA or morphine dose-dependently reduced the mechanical allodynia-like behavior, with a threshold of 1 nmol and 1.5 nmol, respectively. When co-administrated, R-PIA and morphine produced marked suppression of mechanical allodynia at doses of 5 pmol and 7.5 pmol, respectively. The effect of i.t. co-administration of R-PIA and morphine on cold allodynia was comparable to i.t. R-PIA alone. The combination of R-PIA and morphine did not increase adverse effects such as motor deficits in comparison to either drug alone.
CONCLUSION: These results demonstrate a supra-additive interaction between the adenosine A1-receptor agonist R-PIA and morphine to reduce mechanical allodynia-like behavior in rats with chronic spinal cord injury. The combination of R-PIA and morphine administered spinally may be superior to R-PIA or morphine alone for treating such pain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903013     DOI: 10.1034/j.1399-6576.2000.440606.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  4 in total

Review 1.  Adenosine receptors: Emerging non-opioids targets for pain medications.

Authors:  Soo-Min Jung; Lee Peyton; Hesham Essa; Doo-Sup Choi
Journal:  Neurobiol Pain       Date:  2022-03-25

2.  The interaction of gabapentin and N6-(2-phenylisopropyl)-adenosine R-(-)isomer (R-PIA) on mechanical allodynia in rats with a spinal nerve ligation.

Authors:  Jong Yeon Park; In Gu Jun
Journal:  J Korean Med Sci       Date:  2008-08       Impact factor: 2.153

3.  Pilot prospective open-label one-arm trial investigating intrathecal Adenosine in neuropathic pain after lumbar discectomy.

Authors:  Dawood Aghamohammadi; Mahmood Eydi; Alireza Pishgahi; Azam Esmaeilinejad; Neda Dolatkhah
Journal:  BMC Res Notes       Date:  2020-06-12

Review 4.  Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain.

Authors:  Fabrizio Vincenzi; Silvia Pasquini; Pier Andrea Borea; Katia Varani
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.